SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome

PHASE2TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Myelodysplastic Syndrome
Interventions
DRUG

Azacitidine

Azacitidine

DRUG

Beta Erythropoietin

Beta Erythropoietin

Trial Locations (10)

Unknown

Hospital Germans Trias i Pujol, Badalona

Hospital Clínic Universitari, Barcelona

Hospital del Mar, Barcelona

Hospital Reina Sofía, Córdoba

Hospital Virgen Blanca, León

Hospital la Paz, Madrid

Hospital Central de Asturias, Oviedo

Hospital Son Llatzer, Palma de Mallorca

Hospital Clinico Universitario, Salamanca

Hospital La Fe de Valencia, Valencia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Celgene Corporation

INDUSTRY

lead

PETHEMA Foundation

OTHER